Substituted dihydroimidazoles and their use in the treatment of tumors

Details for Australian Patent Application No. 2007327621 (hide)

Owner Novartis AG

Inventors Chamoin, Sylvie; Roth, Hans-Jorg; Zimmermann, Juerg; Zoller, Thomas

Agent Davies Collison Cave

Pub. Number AU-A-2007327621

PCT Pub. Number WO2008/065068

Priority 06124802.7 27.11.06 EP

Filing date 26 November 2007

Wipo publication date 5 June 2008

International Classifications

C07D 233/40 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/4178 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

4 June 2009 PCT application entered the National Phase

  PCT publication WO2008/065068 Priority application(s): WO2008/065068

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007327653-Substituted estratrien derivatives as 17beta HSD inhibitors

2007327614-Duct element for air handling systems